Sirolimus-analog-eluting stents for treatment of coronary artery disease
Record ID 32011000913
English
Authors' objectives:
Sirolimus-analog-eluting coronary stents are device/drug combination products consisting of a coronary stent system and an antiproliferative drug. The drug-eluting stents are used for the minimally invasive treatment of coronary artery obstruction in patients with symptomatic coronary artery disease who require percutaneous coronary angioplasty and stenting. The drug-eluting stents combine the mechanical scaffolding properties of metallic stents with the site-specific delivery of an antiproliferative agent designed to inhibit vascular responses to arterial injury, thereby reducing restenosis.
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=11869
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Angioplasty, Balloon, Coronary
- Coronary Artery Disease
- Sirolimus
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.